radiation oncology

MVision AI: your data is protected!
MVision AI not only provides unique AI-powered solutions for Radiotherapy treatment planning but also follows the highest standards of data protection for clinics and their…
Improving Tools to Fight Glioblastoma
 Background Glioblastoma multiforme represents approximately half of the cases of central nervous system malignant tumors. The median age at diagnosis is 64 years, and the…
Medron Medical Systems Inc. is Introducing MVision’s Groundbreaking Auto-Segmentation Solution to Canada
Helsinki – December 9, 2021 – MVision AI, the leading software service provider of guideline-based AI segmentation, GBAIS™, for radiotherapy treatment planning, declares a new…